Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling

Related articles

1. Integrative In Silico Transcriptomic and Pharmacogenomic Analysis of CD276 as a Candidate Prognostic Biomarker and Therapeutic Target in Bladder Cancer

   This article has 8 authors:

   1. Faruk Recep Özalp
   2. Halil İbrahim Ellez
   3. Ahmet Melih Arslan
   4. Erkut Demirciler
   5. Savaş Gökçek
   6. Oktay Halit Aktepe
   7. Hüseyin Salih Semiz
   8. Aziz Karaoğlu

2. Combined treatment of thymoquinone and embelin epigenetically attenuates epithelial-to-mesenchymal transition inducing tumor regression by efficiently suppressing stemness factors through EGFR-RAS-MAPK axis colonospheres

   This article has 7 authors:

   1. Ankan Roy
   2. Veerbhan Kesarwani
   3. Piyasa Nandi
   4. Subhajit Chakraborty
   5. Niharika .
   6. Ravi Shankar
   7. Samir Kumar Patra

3. Single-cell analysis reveals a kynurenine pathway enriched epithelial subpopulation and a HAAO/QA-FDPS metabolic axis in prostate cancer

   This article has 11 authors:

   1. Lin Wang
   2. Chang Zhang
   3. Ting Feng
   4. Xue Lv
   5. Zhu Shao
   6. Chang Gong
   7. Ruiying Chen
   8. Ruo Zhang
   9. Yong Hou
   10. xiang Han
   11. Di Wang